Elizabeth Ahern

7PUBLICATIONS
25CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 12, 2024
Sacituzumab Govitecan in Patients with Relapsed/Refractory Advanced Head and Neck Squamous Cell Carcinoma: Results from the Phase II TROPiCS-03 Basket Study.

Loren Michel, Antonio Jimeno, Ammar Sukari

|Jun 04, 2021
Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time?

Elizabeth Ahern, Ben J Solomon, Rina Hui

|Sep 26, 2020
Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real-world multi-institution cohort study.

Anna Kuchel, Elizabeth Ahern, Stephanie Collins

|Jun 11, 2020
Retrospective analysis of hospital admissions due to immune checkpoint inhibitor-induced immune-related adverse events (irAE).

Elizabeth Ahern, Michael J Allen, Andrew Schmidt

|Apr 30, 2020
Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma.

Ailin Lepletier, Jason Madore, Jake S O'Donnell

Pageof 2